Poglitazone promotes insulin-induced activation of phosphoinositide 3-kinase in 3T3-L1 adipocytes by inhibiting a negative control mechanism
- 31 July 1994
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 103 (1-2) , 1-12
- https://doi.org/10.1016/0303-7207(94)90063-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Hepatic insulin resistance in KKAy mice and its amelioration by pioglitazone do not involve alterations in phospholipase C activityBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
- The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domainsDiabetes, 1993
- Insulin Stimulates the Degradation of IRS-1 in 3T3-L1 AdipocytesBiochemical and Biophysical Research Communications, 1993
- Insulin Stimulates Phosphatidylinositol‐3‐Kinase activity in rat adipocytesEuropean Journal of Biochemistry, 1992
- The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistanceDiabetologia, 1991
- Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulationPublished by Elsevier ,1991
- Phosphoinositide kinasesBiochemistry, 1990
- Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob miceDiabetes, 1990
- Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetesThe American Journal of Medicine, 1988
- Ciglitazone reverses cAMP‐induced post‐insulin receptor resistance in rat adipocytes in vitroFEBS Letters, 1984